Brooksville, FL – According to filings with the U.S. Securities and Exchange Commission, American Injectables is raising $19,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Adam Levitt played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About American Injectables
American Injectables is a US-based manufacturer of sterile injectable parenteral drugs with a world-class facility focused on ready-to-use pre-filled syringes and vials. The company’s product line includes small molecule 505(b)2 and 505(j) ready-to-use syringe and vial products, and it serves as an out-sourced contract manufacturing partner for strategic pharmaceutical companies.

To learn more about American Injectables, visit http://www.americaninj.com/

Contact:
Adam Levitt, Chief Executive Officer
813-435-6014
adam@americaninj.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved